New information on the immune response to TB might aid the development of vaccines

New information on the immune response to TB might aid the development of vaccines ...

The Mycobacterium tuberculosis, the bacterial strain that causes tuberculosis, has spread to the United States, but the current TB vaccinations are only partially protective. New research by a team of researchers at Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), Harvard, and the Harvard T.H. Chan School of Public Health (Harvard Chan) has discovered useful and unhelpful aspects of the immune response. These findings, which are published inImmunity, may

In some cases, the body''s immune system can often keepM. tuberculosisinfections under control so that individuals don''t experience any symptoms. In some cases, there were more than 10 million active cases in 2017, which totaled 1.6 million TB fatalities. In response to an active infection, the body forms granulomastiny clusters of immune cells and other tissue-resident cells. In some cases, immune activity stimulates bacterial clearance, but in others, bacteria persist and grow.

Scientists in the lab of JoAnne Flynn, a researcher at the University of Pittsburgh, used their unique-cell profiling tools to create a monkey model that explains human TB and identified bacterial loads and killing patterns.

With TB, the immune response is pretty good but not great, and until recently, the field has dealt with that problem with very rudimentary tools. This collaboration is bringing the very best tools and the very best minds to bear on a really tough, really important issue that most of the world ignores, according to cosenior author Sarah Fortune, who is an associate member of the Ragon Institute.

granulomas that supported bacterial clearance are classified as cells with specific types of cells, including type 1-type 17, stem-like, and cytotoxic T cells.

According to Shalek, new objectives are highlighted as specific cell subsets to guide next-generation vaccinations. We can also begin to consider how we might directly manipulate entire granulomas through intercellular signaling to combat the bug more effectively.

TB is the most important component of how we can be effective in controlling COVID-19, which is due to a virus, and its ability to transmit before people are diagnosed, according to Fortune. Unlike COVID-19, which is caused by bacteria, TB is caused by bacteria, and this method has involved several months of aggressive antibiotic therapy. TB is crucial in understanding what a new vaccination should do, according to Forbes.

This collaboration was funded by the Bill and Melinda Gates Foundation, the Searle Scholars Program, the Beckman Young Investigator Program, the Sloan Fellowship in Chemistry, the National Institutes of Health, the American Lung Association, the National Science Foundation, the Fannie and John Hertz Foundation Fellowship, and the Wellcome Trust Fellowship.

You may also like: